Moreover, because the Ro1 receptor is a GPCR and is restricted to GFAP-positive cells, this model enables the investigation of specific signaling cascades that may cause hydrocephalus, which may lead to the development of novel drug-based therapeutics to treat this disorder. Here, GFAP is linked to Hydrocephalus.